830 
Keywords: implementation, pmtct of HIV, HIV therapy 
INTRODUCTION 
Globally, the year 2018 saw approximately 37.9 million individuals living with 
HIV/AIDS, with a significant majority, roughly 69 percent (around 19.4 million), 
located  in  sub-Saharan  Africa  (WHO/GHO,  2019).  Despite  the  widespread 
administration  of  progressive  antiretroviral  therapy,  nearly  74  percent  of  the  1.5 
million AIDS-related  deaths  in  2013  occurred  in  this  region  (Kharsany  &  Karim, 
2016).  In  terms  of  gender,  women  worldwide  have  borne  the  heaviest  burden  of 
HIV/AIDS  (Ramjee & Daniels, 2013).  Shockingly,  it  was  estimated that  a  young 
woman was infected with HIV almost every minute (UNAIDS, 2012). Sub-Saharan 
Africa, in particular, has been severely impacted, with females accounting for at least 
56–59% of People Living with HIV/AIDS (PLWHAs) (Kharsany & Karim, 2016; 
Ramjee & Daniels, 2013; Sia et al., 2016). In the sub-region, young girls aged 15–19 
years old make up 75% of new infections, and women in the 15–24 age group are 
twice as likely to be living with HIV compared to their male counterparts (NACP, 
2009). Furthermore, in 2017, 79% of HIV incidence in southern and eastern Africa 
occurred among adolescent females aged 10–19 years (Brown et al., 2018). 
According to data from the National AIDS Control Program (NACP) in 2018, 
the female population in Ghana comprised 65% of the estimated 334,713 individuals 
living  with  HIV/AIDS  (PLWHAs),  whereas  males  formed  35%  of  the  total.  The 
gender difference in HIV infection and its consequences for women can be ascribed 
to the unequal cultural and socio-economic standing they hold in comparison to men 
(Higgins  et  al.,  2010;  Igulot  &  Magadi,  2018).  Therefore,  it  is  imperative  to 
implement interventions aimed at preventing or mitigating the transmission of HIV 
from women to men or children, with a particular focus on pregnant women. The 
transmission  of  HIV  from  mother  to  child,  also  known  as  mother-to-child 
transmission (MTCT), continues to pose a substantial obstacle in the context of the 
worldwide  HIV  pandemic.  In  the  absence  of  preventative  interventions,  the 
likelihood of HIV transmission to newborns throughout the course of pregnancy or 
childbirth varies between 15 and 30 percent, and this risk escalates to a range of 20 
to  45  percent  when  nursing  is  practiced.  The  implementation  of  Prevention  of 
Mother-to-Child Transmission (PMTCT) measures has proven effective in mitigating 
vertical HIV transmission to below one percent in industrialized nations. However, 
middle- and low-income countries have encountered very limited achievements  in 
this regard. Pregnant women who are infected  with  HIV  face  a significant risk  of 
transferring  the  virus  to  their  offspring  through  mother-to-child  transmission 
(MTCT). This is a prominent issue in sub-Saharan African nations characterized by 
elevated  fertility  rates  and  a  high  prevalence  of  HIV  among  women  in  their 
reproductive  years  (UNAIDS  and  JC2137E,  2011).  Mother-to-child  transmission 
(MTCT) is the primary cause of more than 90% of newly acquired HIV infections in 
babies, as reported by the World Health Organization in 2007 (Petersen, 2008). 
Prevention  of  mother-to-child  transmission  (PMTCT)  is  a  holistic  strategy 
designed  to  encompass  several  interventions  targeting  the  prevention,  care, 
treatment, and support services for mothers who are HIV-positive and their offspring, 
spanning from the prenatal period to early childhood. According to Ngonyani et al. 
(2012), this strategy has played a pivotal role in decreasing HIV infection rates among 
the community and effectively eradicating HIV transmission to children on a global